tiprankstipranks
Trending News
More News >
Affymax (AFFY)
OTHER OTC:AFFY
US Market

Affymax (AFFY) Price & Analysis

Compare
20 Followers

AFFY Stock Chart & Stats

<$0.01
<$0.01(200.00%)
At close: 4:00 PM EST
<$0.01
<$0.01(200.00%)

AFFY FAQ

What was Affymax’s price range in the past 12 months?
Affymax lowest stock price was <$0.01 and its highest was $0.04 in the past 12 months.
    What is Affymax’s market cap?
    Affymax’s market cap is $29.99K.
      When is Affymax’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Affymax’s earnings last quarter?
      Currently, no data Available
      Is Affymax overvalued?
      According to Wall Street analysts Affymax’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Affymax pay dividends?
        Affymax pays a Monthly dividend of $0.05 which represents an annual dividend yield of N/A. See more information on Affymax dividends here
          What is Affymax’s EPS estimate?
          Affymax’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Affymax have?
          Affymax has 37,490,000 shares outstanding.
            What happened to Affymax’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Affymax?
            Currently, no hedge funds are holding shares in AFFY
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Company Description

              Affymax

              Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
              Similar Stocks
              Company
              Price & Change
              Follow
              Scinai Immunotherapeutics
              Artelo Biosciences
              PainReform
              Dermata Therapeutics
              Virax Biolabs Group Ltd. Class A

              Ownership Overview

              <0.01%99.99%
              Insiders
              Mutual Funds
              <0.01% Other Institutional Investors
              99.99% Public Companies and
              Individual Investors

              Options Prices

              Currently, No data available
              ---
              Popular Stocks